News

Editor's Top Picks

The right will want a United States of Europe

Stay informed with free updatesSimply sign up to the Life & Arts myFT Digest -- delivered directly to your inbox.Auberon

News

Your one-stop resource for personal news and tips.

Join our newsletter to get the latest news directly to your inbox.

More form News

Meta Platforms: Big Rally And Yet Still Cheap (Rating Upgrade)

Meta Platforms, Inc. (NASDAQ:META) investors who stayed on the ride have likely been unable to

UBS shakes up Middle East wealth management team

Receive free UBS Group AG updatesWe’ll send you a myFT Daily Digest email rounding up

DexCom: Fantastic Growth But A High Premium To Pay Right Now (NASDAQ:DXCM)

Investment Outline Looking at the stock chart over the last 5 years for DexCom (NASDAQ:DXCM)

Yield on two-year Treasury note hits highest level since 2007

Receive free US interest rates updatesWe’ll send you a myFT Daily Digest email rounding up

St. James Investment Company Value Investor’s Q2 2023 Quarterly Letter

The only true wisdom is in knowing you know nothing - Socrates On the fiftieth

Volodymyr Zelenskyy vows strong response to Russian strike on Lviv

Receive free War in Ukraine updatesWe’ll send you a myFT Daily Digest email rounding up

Talkspace: Turnaround Continues; An Open-Ended Growth Opportunity Comes Into View

Re-Cap of My Last Report This is a follow-up to my March 27, 2023 report,

Volodymyr Zelenskyy seeks more military aid on Bulgaria visit

Receive free War in Ukraine updatesWe’ll send you a myFT Daily Digest email rounding up

Enovix Stock: Wins Army Contract, Game-Changing Milestone (NASDAQ:ENVX)

Investment Thesis Enovix Corporation (NASDAQ:ENVX) announced an important milestone. The company signals that it's been

Generali snaps up Conning to create one of Europe’s largest asset managers

Receive free Assicurazioni Generali SpA updatesWe’ll send you a myFT Daily Digest email rounding up

AbbVie Stock: ‘Hold’ In The Short Term, ‘Buy’ On Humira-Inspired Dips (NYSE:ABBV)

Introduction AbbVie Inc. (NYSE:ABBV), a global pharmaceutical company, focuses on developing and selling diverse medical

European tech investors need to up their ambitions

Receive free Tech start-ups updatesWe’ll send you a myFT Daily Digest email rounding up the

Brookfield Renewable Continues To Help Reduce Our Reliance On Fossil Fuels (NYSE:BEP)

Introduction My thesis is that Brookfield Renewable (NYSE:BEP) (NYSE:BEPC) continues doing their part to help

FIS agrees to sell majority stake in Worldpay to buyout group for up to $18.5bn

Receive free Worldpay Inc updatesWe’ll send you a myFT Daily Digest email rounding up the

Is Nike Stock A Buy? Market Pessimism Creates An Opening (NYSE:NKE)

Nike (NYSE:NKE) has lost about 5% since their last earnings release. The stock, however, appears